ANAPTYSBIO, INC — Director's Dealing 2017

Jul 28, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANAPTYSBIO INC (ANAB)
CIK: 0001370053
Period of Report: 2017-07-26

Reporting Person: Avalon Ventures VII L P (10% Owner)
Reporting Person: AVALON VENTURES VII GP, LLC (10% Owner, See Remarks)
Reporting Person: Kinsella Kevin J (10% Owner, See Remarks)
Reporting Person: Tomlin Stephen Lawrence (10% Owner, See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-07-26	Common Stock	J	399987	$0.00	Disposed	1636945	Indirect
2017-07-26	Common Stock	J	37040	$0.00	Acquired	37040	Indirect
2017-07-26	Common Stock	S	37040	$24.35	Disposed	0	Indirect

Footnotes

F1: Represents a pro-rata in-kind distribution of Common Stock by Avalon Ventures VII, L.P. effected on July 26, 2017 without consideration to its limited partners and to its general partner, Avalon Ventures VII GP, LLC.

F2: Represents the receipt by Avalon Ventures VII GP, LLC, the general partner of Avalon Ventures VII, L.P., of its pro-rata portion of the in-kind distribution described in footnote 1.

F3: Represents the open-market sale by Avalon Ventures VII GP, LLC, the general partner of Avalon Ventures VII, L.P., of the Common Stock received as a result of the in-kind distribution described in footnote 1.